liposomal glutathione bioavailability compared to standard – ActiNovo bioavailability of standard oral glutathione

In the case of GSAO, a reversible renal toxicity described in preclinical studies at the maximal tolerated dose was not observed in human during clinical Phase I (Horsley et al., 2013)

Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders

diminuer l'exposition aux polluants organiques, notamment dans lalimentation

Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases

In the case of suspected cobalt hypersensitivity, an intradermal test dose should be administered because anaphylactic shock and death have followed parenteral administration of methylcobalamin